SCHEMBL3673459

SCHEMBL3673459

Clc1cncc(C(CNC2=NCCO2)c2cccc(Cl)c2Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 3/20 0.41
CFB P00751 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3669311 0.90 CFB (0.36) P2RX7CFB
SCHEMBL3674513 0.86 P2RX7 (0.42) P2RX7
SCHEMBL3804488 0.83 TAAR1 (0.40) P2RX7CFB
SCHEMBL3671172 0.78 CFB (0.36) CFB
SCHEMBL3668500 0.77 CFB (0.35) CFB
SCHEMBL3672714 0.75 IDH1 (0.32)
SCHEMBL3670065 0.75 TAAR1 (0.38) P2RX7CFB
SCHEMBL12637702 0.75 CFB (0.33) P2RX7CFB
SCHEMBL3411857 0.75 CFB (0.36) P2RX7CFB
SCHEMBL3433522 0.74 CFB (0.41) CFB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2242753-A1 OXAZOLIDINE AND THIAZOLIDINE SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF ALLERGAN, INC. (US) 2010-10-27 EP disclosed
WO-2009091760-A1 OXAZOLIDINE AND THIAZOLIDINE SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF ALLERGAN, INC. (US) 2009-07-23 WO disclosed